| GLP-1 | Glucagon-Like Peptide 1 |
| GLP-1R | Glucagon-Like Peptide 1 Receptor |
| GLP-1RAs | Glucagon-Like Peptide 1 Receptor Agonists |
| GPCR | G-protein-coupled receptors |
| GIP | Glucose-dependent insulinotropic polypeptide |
| PD | Parkinson’s Disease |
| AD | Alzheimer’s Disease |
| T2DM | Type 2 diabetes mellitus |
| BBB | Blood–brain barrier |
| CNS | Central Nervous System |
| PNS | Peripheral nervous system |
| cAMP | Cyclic Adenosine Monophosphate |
| CREB | cAMP response element-binding protein |
| PKA | Protein Kinase A |
| PI3K | Phosphoinositide 3-Kinase |
| AKT | Protein Kinase B |
| ERK | Extracellular Signal-Regulated Kinase |
| MAPK | Mitogen-activated protein kinases |
| EPAC | Exchange protein activated by cAMP |
| mTOR | Mammalian target of rapamycin |
| GSK-3β | Glycogen synthase kinase-3β |
| FOXO1 | Forkhead box O1 |
| DNA | Deoxyribonucleic acid |
| RNA | Ribonucleic acid |
| APE1 | Apurinic/Apyrimidinic endonuclease 1 |
| BER | Base excision repair |
| Ex4 | Exendin-4 |
| MPZ | Myelin protein zero |
| PMP22 | Peripheral myelin protein 22 |
| IFRS1 | Immortalised Fischer rat Schwann cells |
| MS | Multiple sclerosis |
| IL-1β | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IL-17 | Interleukin-17 |
| TNF-α | Tumour necrosis factor-alpha |
| Th1 | T helper type 1 |
| Th17 | T helper type 17 |
| ROS | Reactive oxygen species |
| HDAC6 | Histone Deacetylase 6 |
| LC3 | Microtubule-associated protein 1A/1B-light chain 3 |
| SCI | Spinal cord injury |
| PtdIns3P | Phosphatidylinositol-3-phosphate |
| AGEs | Advanced glycation end-products |
| NTS | Nucleus tractus solitarius |
| ARC | Arcuate nucleus |
| PVN | Paraventricular nucleus |
| VMH | Ventromedial hypothalamic nucleus |
| DMV | Dorsal motor nucleus of the vagus |
| POMC | Proopiomelanocortin |
| CSF | Cerebrospinal fluid |
| DPP-4 | Dipeptidyl peptidase-4 |
| DPP-4i | Dipeptidyl peptidase-4 inhibitors |
| PYY | Peptide YY |
| LPS | Lipopolysaccharide |
| HFD | High-fat diet |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| SCFAs | Short chain fatty acids |
| GPR41/43 | G protein-coupled receptor 41/43 |
| DKD | Diabetic kidney disease |
| NAFLD | Non-alcoholic fatty liver disease |
| DCA | Deoxycholic acid |
| PBMC | Peripheral blood mononuclear cell |
| IGF-1 | Insulin-like growth factor-1 |
| STAT3 | Signal transducer and activator of transcription |
| APP | Amyloid Precursor Protein |
| PS1 | Presenilin 1 |
| 5xFAD | Five familial Alzheimer’s Disease mutation |
| STZ | Streptozotocin |
| NLRP2 | NLR family pyrin domain containing 2 |
| GluR1 | Glutamate receptor 1 |
| PSD-95 | Postsynaptic density protein-95 |
| BDNF | Brain-derived neurotrophic factor |
| ADAM10 | A disintegrin and metalloproteinase domain-containing protein 10 |
| RCTs | Randomised controlled trials |
| PET | Positron Emission Tomography |